Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Third Quarter of 2025

Issued on  | Posted on  | Report number: OEI-03-26-00040

Report Materials

This memorandum summarizes the results of the Office of Inspector General’s (OIG’s) comparison of average sales prices (ASPs) and average manufacturer prices (AMPs) for the third quarter of 2025. By law, OIG must notify the Secretary of Health and Human Services if the ASP for a particular drug exceeds the drug’s AMP by 5 percent or more. If that threshold is met, the Secretary may disregard the drug’s ASP when setting the reimbursement amount and substitute the lesser of either the widely available market price or 103 percent of the AMP.

Report Type
Evaluation
HHS Agencies
Centers for Medicare and Medicaid Services
Issue Areas
–
Target Groups
–
Financial Groups
–

Notice

This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.